Keri L. Schaubert, Ph.D.

Member

New York

(212) 883-2258

(212) 986-0604

Recent Publication:

Exercising discretion [Intellectual Property Magazine]

Keri Schaubert and Aaron Lukas consider a precedential PTAB order outlining six factors in exercising discretion to deny institution of IPR proceedings.

Keri concentrates her practice on complex patent cases for clients in the pharmaceutical and biotechnology industries. She is a registered patent attorney and represents companies in Hatch-Waxman and biosimilar litigation. Keri handles all aspects of patent cases including pre-suit investigations, fact and expert discovery, dispositive motions, and trials. She also has experience in IPR matters at the PTAB on behalf of both patent owners and challengers.

Prior to attending law school, Keri received her Ph.D. in immunology from Wayne State University School of Medicine where, as a part of her doctoral research, she studied human CD8+ T cell responses to HIV epitopes and mimotopes thereof. Keri then completed a postdoctoral fellowship at the University of Michigan where she examined the role of transforming growth factor-β (TGF-β) in natural killer (NK) cell maturation. Keri has been published in numerous immunology journals.

Keri is a graduate of Loyola University Chicago School of Law, and earned a bachelor’s degree in biology and anthropology from the University of Michigan.

Experience

News

Cozen O’Connor Promotes 20 to Membership

April 08, 2020

Cozen O'Connor is pleased to recognize 20 attorneys with the promotion to member.

Publications

Exercising discretion [Intellectual Property Magazine]

July 09, 2020

Keri Schaubert and Aaron Lukas consider a precedential PTAB order outlining six factors in exercising discretion to deny institution of IPR proceedings.

PTAB Settlement Disclosure Timing Crucial After DTN Ruling [Law 360]

July 07, 2020

Aaron Lukas and Keri Schaubert wrote an article on the Patent Trial and Appeal Board decision in DTN LLC v. Farms Technology LLC.

The Trans-Pacific Partnership and Its Effect On Biosimilars [Inside Counsel]

November 23, 2015

Aaron Lukas and Keri Schaubert, associates of Cozen O’Connor’s IP group, discuss the effect that the Trans-Pacific Partnership will have on the biopharmaceutical and biosimilar industry.

Education

  • Loyola University Chicago School of Law, J.D., 2013
  • Wayne State University of Medicine, Ph.D., 2006
  • University of Michigan, B.S., 2000
  • Illinois
  • United States Patent and Trademark Office